Michael Burgess
Chief Tech/Sci/R&D Officer bei TURNSTONE BIOLOGICS CORP.
Vermögen: - $ am 31.03.2024
Aktive Positionen von Michael Burgess
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Director/Board Member | 07.05.2021 | - |
| Chief Tech/Sci/R&D Officer | 01.10.2017 | - | |
| The Royal College of Physicians | Corporate Officer/Principal | - | - |
| The Royal College of Paediatrics & Child Health | Corporate Officer/Principal | - | - |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Director/Board Member | 20.07.2022 | - |
Karriereverlauf von Michael Burgess
Ehemalige bekannte Positionen von Michael Burgess
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SYNLOGIC, INC. | Director/Board Member | 01.01.2020 | 20.03.2024 |
| Independent Dir/Board Member | 01.01.2020 | 20.03.2024 | |
| SPRINGWORKS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 10.05.2021 | 16.09.2022 |
Roche Holding (UK) Ltd.
 Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Corporate Officer/Principal | 01.01.2010 | 01.01.2010 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01.01.2010 | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 17.01.2013 | - |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Michael Burgess
| University of Bristol | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Vereinigtes Königreich | 5 |
| Schweiz | 2 |
Operativ
| Corporate Officer/Principal | 7 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Health Technology | 9 |
| Consumer Services | 4 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| SYNLOGIC, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Roche Holding (UK) Ltd.
Roche Holding (UK) Ltd. Pharmaceuticals: MajorHealth Technology Roche Holding (UK) Ltd. manufactures and sells drugs. It operates as a holding company for Roche Products Ltd. and Roche Diagnostics Ltd. Its pharmaceuticals include Copegus, a hepatitis C therapy, HIV inhibitor Fuzeon, and breast cancer therapy, Herceptin. The firm's consumer and professional tests include Accutrend glucose monitoring systems, CoaguChek blood coagulation tests, and the Amplicor line of DNA disease diagnostics. The company was founded in 1908 and is headquartered in Welwyn Garden City, UK. | Health Technology |
Roche Ltd.
 Roche Ltd. Financial ConglomeratesFinance Roche Ltd. provides investment services. | Finance |
iOmx Therapeutics AG
iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany. | Health Technology |
- Börse
- Insiders
- Michael Burgess
- Erfahrung
